Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

Density Estimation for Statistics and Data Analysis

2018 • 15,477 citations

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1999 • 11,707 citations

The Statistical Analysis of Failure Time Data.

1981 • 10,224 citations

Density Estimation for Statistics and Data Analysis

1400 • 8,320 citations

Modeling Survival Data: Extending the Cox Model

2000 • 7,620 citations

Bootstrap Methods and their Application

1997 • 6,538 citations

Bootstrap Methods and Their Application

1999 • 5,712 citations

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

1988 • 4,727 citations

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2003 • 3,532 citations

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

2013 • 1,881 citations

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

2010 • 1,604 citations

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2010 • 1,520 citations

Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors

1994 • 1,107 citations

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

1984 • 989 citations

The Statistical Analysis of Failure Time Data.

1982 • 927 citations

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

1984 • 919 citations

A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group

1998 • 823 citations

Competing risk analysis using R: an easy guide for clinicians

2007 • 664 citations

Multivariable Model‐Building

2008 • 642 citations

Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables

2008 • 614 citations

International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

2009 • 612 citations

On Estimation in Relative Survival

2011 • 546 citations

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

2011 • 473 citations

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

2012 • 441 citations

Regression modeling of competing risk using R: an in depth guide for clinicians

2010 • 430 citations

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

2010 • 378 citations

Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs

2005 • 328 citations

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

2011 • 320 citations

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

2013 • 287 citations

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

2015 • 216 citations

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

2011 • 189 citations

Cancer clinical trials: methods and practice

1985 • 176 citations

Relative survival analysis in R

2006 • 173 citations

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia

2012 • 170 citations

Model selection in competing risks regression

2013 • 118 citations

Non‐parametric confidence interval estimation for competing risks analysis: application to contraceptive data

2002 • 106 citations

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party

2011 • 104 citations

Differences among young adults, adults and elderly chronic myeloid leukemia patients

2014 • 84 citations

Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

2013 • 68 citations

Unstable Alpha Hemoglobin Stabilizing Protein as a Cause of Thalassemia: Proof of Concept.

2009 • 67 citations

Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia

2011 • 63 citations

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib

2013 • 63 citations

Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group

2010 • 61 citations

Chronic Myeloid Leukemia: Biology and Treatment

2007 • 26 citations

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia

2008 • 24 citations

Frontline Treatment With Imatinib Mesylate in Chronic Myeloid Leukemia Patients in Early Chronic Phase: a Very Long-Term Analysis by the GIMEMA CML Working Party

2013 • 2 citations

Deleted Work

1955 • 0 citations